LDL receptor expression on T lymphocytes in old patients with Down syndrome

Massimiliano M. Corsi, Alexis E. Malavazos, Daniele Passoni, Federico Licastro

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: In Down syndrome patients several metabolic abnormalities have been reported, some involving the lipid metabolism. The level of LDL in plasma is the major determinant of the risk of vascular disease. There appear to be no studies on the LDL receptor in Down syndrome patients. Methods: Flow cytometric methods for measuring the LDL receptor in peripheral blood mononuclear cells (PBMC) can identify patients with hypercholesterolemia. We applied this method in 19 old patients with Down syndrome and 23 healthy controls. Results: Down syndrome patients had high levels of triglycerides and low levels of HDL, and high levels of CRP. We also found a down-regulation of LDL receptor expression. Conclusions: Down syndrome patients show no increase in the frequency of cardiovascular disease. The low incidence in cardiovascular disease despite the low level of HDL, high levels of CRP and reduction of LDL receptor expression lead to the conclusion that either these are not risk factors in these patients or that other risks factors - not yet identified - are considerably lower.

Original languageEnglish
Article number3
JournalImmunity and Ageing
Volume2
DOIs
Publication statusPublished - Feb 10 2005

Fingerprint

LDL Receptors
Down Syndrome
T-Lymphocytes
Cardiovascular Diseases
Hypercholesterolemia
Vascular Diseases
Lipid Metabolism
Blood Cells
Triglycerides
Down-Regulation
Incidence
low density lipoprotein inhibitor

ASJC Scopus subject areas

  • Ageing
  • Immunology

Cite this

LDL receptor expression on T lymphocytes in old patients with Down syndrome. / Corsi, Massimiliano M.; Malavazos, Alexis E.; Passoni, Daniele; Licastro, Federico.

In: Immunity and Ageing, Vol. 2, 3, 10.02.2005.

Research output: Contribution to journalArticle

@article{36e7927b06a547549424fc5c6c1bfa23,
title = "LDL receptor expression on T lymphocytes in old patients with Down syndrome",
abstract = "Background: In Down syndrome patients several metabolic abnormalities have been reported, some involving the lipid metabolism. The level of LDL in plasma is the major determinant of the risk of vascular disease. There appear to be no studies on the LDL receptor in Down syndrome patients. Methods: Flow cytometric methods for measuring the LDL receptor in peripheral blood mononuclear cells (PBMC) can identify patients with hypercholesterolemia. We applied this method in 19 old patients with Down syndrome and 23 healthy controls. Results: Down syndrome patients had high levels of triglycerides and low levels of HDL, and high levels of CRP. We also found a down-regulation of LDL receptor expression. Conclusions: Down syndrome patients show no increase in the frequency of cardiovascular disease. The low incidence in cardiovascular disease despite the low level of HDL, high levels of CRP and reduction of LDL receptor expression lead to the conclusion that either these are not risk factors in these patients or that other risks factors - not yet identified - are considerably lower.",
author = "Corsi, {Massimiliano M.} and Malavazos, {Alexis E.} and Daniele Passoni and Federico Licastro",
year = "2005",
month = "2",
day = "10",
doi = "10.1186/1742-4933-2-3",
language = "English",
volume = "2",
journal = "Immunity and Ageing",
issn = "1742-4933",
publisher = "BioMed Central",

}

TY - JOUR

T1 - LDL receptor expression on T lymphocytes in old patients with Down syndrome

AU - Corsi, Massimiliano M.

AU - Malavazos, Alexis E.

AU - Passoni, Daniele

AU - Licastro, Federico

PY - 2005/2/10

Y1 - 2005/2/10

N2 - Background: In Down syndrome patients several metabolic abnormalities have been reported, some involving the lipid metabolism. The level of LDL in plasma is the major determinant of the risk of vascular disease. There appear to be no studies on the LDL receptor in Down syndrome patients. Methods: Flow cytometric methods for measuring the LDL receptor in peripheral blood mononuclear cells (PBMC) can identify patients with hypercholesterolemia. We applied this method in 19 old patients with Down syndrome and 23 healthy controls. Results: Down syndrome patients had high levels of triglycerides and low levels of HDL, and high levels of CRP. We also found a down-regulation of LDL receptor expression. Conclusions: Down syndrome patients show no increase in the frequency of cardiovascular disease. The low incidence in cardiovascular disease despite the low level of HDL, high levels of CRP and reduction of LDL receptor expression lead to the conclusion that either these are not risk factors in these patients or that other risks factors - not yet identified - are considerably lower.

AB - Background: In Down syndrome patients several metabolic abnormalities have been reported, some involving the lipid metabolism. The level of LDL in plasma is the major determinant of the risk of vascular disease. There appear to be no studies on the LDL receptor in Down syndrome patients. Methods: Flow cytometric methods for measuring the LDL receptor in peripheral blood mononuclear cells (PBMC) can identify patients with hypercholesterolemia. We applied this method in 19 old patients with Down syndrome and 23 healthy controls. Results: Down syndrome patients had high levels of triglycerides and low levels of HDL, and high levels of CRP. We also found a down-regulation of LDL receptor expression. Conclusions: Down syndrome patients show no increase in the frequency of cardiovascular disease. The low incidence in cardiovascular disease despite the low level of HDL, high levels of CRP and reduction of LDL receptor expression lead to the conclusion that either these are not risk factors in these patients or that other risks factors - not yet identified - are considerably lower.

UR - http://www.scopus.com/inward/record.url?scp=33845204029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845204029&partnerID=8YFLogxK

U2 - 10.1186/1742-4933-2-3

DO - 10.1186/1742-4933-2-3

M3 - Article

VL - 2

JO - Immunity and Ageing

JF - Immunity and Ageing

SN - 1742-4933

M1 - 3

ER -